{"id":10301,"date":"2025-10-19T21:27:49","date_gmt":"2025-10-19T19:27:49","guid":{"rendered":"http:\/\/pepticore-aminos.local\/?post_type=product&#038;p=10301"},"modified":"2026-06-03T11:37:43","modified_gmt":"2026-06-03T09:37:43","slug":"tesamorelin-peptide","status":"publish","type":"product","link":"https:\/\/pepticoreaminos.us\/en\/product\/tesamorelin-peptide\/","title":{"rendered":"Tesamorelin 5mg"},"content":{"rendered":"<section class=\"product-description\" lang=\"it\">\n<header>\n<h1>Tesamorelin<\/h1>\n<p class=\"subtitle\">GHRH analogue for research on HIV-associated lipodystrophy, lipid metabolism, cardiovascular health, peripheral nerve regeneration, and mild cognitive impairment (MCI)<\/p>\n<\/header>\n<article id=\"cos-e\">\n<h3>What is Tesamorelin<\/h3>\n<p class=\"translation-block\"><strong>Tesamorelin<\/strong> is a synthetic analogue of the <strong>growth hormone\u2013releasing hormone (GHRH)<\/strong> composed of 44 amino acids. Compared to native GHRH, it contains an added <strong>trans-3-hexanoic group<\/strong> that enhances its <strong>plasma stability<\/strong> and extends its <strong>half-life<\/strong> while maintaining the <strong>natural pulsatility of growth hormone (GH)<\/strong> secretion.\nThis improved stability allows Tesamorelin to deliver more consistent biological activity with a favorable safety profile. In <strong>2010, the FDA approved Tesamorelin<\/strong> for the treatment of <strong>HIV-associated lipodystrophy<\/strong>, and it remains a key compound in the study of <strong>metabolic regulation<\/strong> and <strong>neuroendocrine signaling<\/strong>.<\/p>\n<\/article>\n<article id=\"meccanismo\">\n<h3>Mechanism of Action<\/h3>\n<p class=\"translation-block\">As a <strong>GHRH analogue<\/strong>, Tesamorelin binds to <strong>pituitary GHRH receptors<\/strong> and triggers a <strong>pulsatile release of GH<\/strong>, which in turn increases <strong>IGF-1 levels<\/strong>.\nThe rise in GH and IGF-1 promotes <strong>lipolysis<\/strong>, enhances <strong>protein synthesis<\/strong>, and supports <strong>metabolic homeostasis<\/strong>.\nThe <strong>trans-3-hexanoic modification<\/strong> confers resistance to enzymatic degradation, improving <strong>bioavailability<\/strong> while maintaining receptor selectivity.\nUnlike continuous GH administration, Tesamorelin preserves the <strong>physiological feedback mechanisms<\/strong> of the hypothalamic\u2013pituitary axis, reducing side effects and maintaining a natural hormonal rhythm.<\/p>\n<\/article>\n<article id=\"lipodistrofia\">\n<h3>Tesamorelin and HIV-Associated Lipodystrophy<\/h3>\n<p class=\"translation-block\"><strong>HIV-associated lipodystrophy<\/strong> results from both HIV infection and prolonged exposure to <strong>antiretroviral therapy<\/strong>, particularly protease inhibitors, leading to abnormal <strong>visceral fat accumulation<\/strong>.\nClinical research demonstrates that <strong>Tesamorelin can reduce visceral adipose tissue (VAT) by approximately 20%<\/strong> in responding patients \u2014 making it roughly <strong>four times more effective<\/strong> than all other therapies combined.\nBefore Tesamorelin, available options were limited to diet, exercise, or surgical removal of fat \u2014 all with limited and inconsistent results.\nBy restoring more balanced fat distribution and improving <strong>lipid metabolism<\/strong>, Tesamorelin represents a targeted approach to metabolic rehabilitation in this population.<\/p>\n<\/article>\n<article id=\"cardio\">\n<h3>Cardiovascular and Lipid Metabolism Effects<\/h3>\n<p class=\"translation-block\">People living with HIV have an elevated risk of <strong>cardiovascular disease (CVD)<\/strong> due to metabolic alterations and drug-induced inflammation.\nResearch shows that Tesamorelin not only decreases VAT but also reduces <strong>triglycerides<\/strong>, <strong>total cholesterol<\/strong>, and <strong>non-HDL cholesterol<\/strong>.\nA <strong>15% reduction in VAT<\/strong> corresponds to an approximate <strong>50 mg\/dL decrease in triglyceride levels<\/strong>, indicating a strong correlation between adiposity and lipid improvement.\nBy reducing <strong>ectopic fat deposition<\/strong> (visceral, hepatic, and epicardial), Tesamorelin directly lowers systemic inflammation and overall CVD risk, complementing standard interventions such as <strong>statins<\/strong> and <strong>lifestyle modification<\/strong>.<\/p>\n<\/article>\n<article id=\"gh-hiv\">\n<h3>Growth Hormone Deficiency and HAART Therapy<\/h3>\n<p class=\"translation-block\">Up to one-third of patients receiving <strong>highly active antiretroviral therapy (HAART)<\/strong> show evidence of <strong>growth hormone deficiency (GHD)<\/strong>.\nThis dysfunction of the <strong>hypothalamic-pituitary axis<\/strong> contributes to the metabolic abnormalities and central adiposity seen in HIV-positive individuals.\nTesamorelin, by restoring physiological GH release, offers a <strong>safer and more controlled alternative<\/strong> to exogenous GH administration, promoting natural endocrine balance while avoiding excessive hormone exposure.<\/p>\n<\/article>\n<article id=\"nervi\">\n<h3>Peripheral Nerve Regeneration<\/h3>\n<p class=\"translation-block\">Peripheral nerve damage, whether from trauma, diabetes, or surgery, remains difficult to treat because of the limited regenerative capacity of neurons.\nPreclinical studies suggest that <strong>GH and IGF-1 pathways<\/strong> enhance nerve healing and axonal growth.\nGiven its established clinical profile, <strong>Tesamorelin<\/strong> is emerging as a promising research candidate for <strong>peripheral nerve repair<\/strong>, potentially improving both the rate and extent of functional recovery after injury.<\/p>\n<\/article>\n<article id=\"cognitivo\">\n<h3>Tesamorelin and Cognitive Function (Mild Cognitive Impairment)<\/h3>\n<p class=\"translation-block\">There is growing evidence that <strong>GHRH analogues<\/strong> like Tesamorelin can improve <strong>cognitive performance<\/strong> in individuals with <strong>mild cognitive impairment (MCI)<\/strong>, a precursor to dementia.\nA randomized, double-blind, placebo-controlled study at the <strong>University of Washington School of Medicine<\/strong> reported significant improvements in <strong>verbal memory<\/strong> and <strong>executive function<\/strong> after 20 weeks of treatment.\nThese effects were associated with increased <strong>gamma-aminobutyric acid (GABA)<\/strong> and decreased <strong>myo-inositol<\/strong> levels in the brain, suggesting enhanced neurochemical balance and potential <strong>neuroprotective action<\/strong>.\nSuch findings open new directions for research into <strong>dementia prevention and neuroendocrine modulation<\/strong>.<\/p>\n<\/article>\n<article id=\"profilo\">\n<h3>Pharmacological Profile and Safety<\/h3>\n<p class=\"translation-block\">The <strong>trans-3-hexanoic modification<\/strong> grants Tesamorelin superior <strong>proteolytic resistance<\/strong> and a convenient dosing interval, while preserving <strong>receptor specificity<\/strong>.\nCompared with other GHRH fragments such as <em>GRF(1-29)<\/em>, <em>Sermorelin<\/em>, or <em>CJC-1295<\/em>, Tesamorelin combines an <strong>extended half-life<\/strong> with the preservation of <strong>natural pulsatile GH secretion<\/strong>.\nPreclinical data indicate <strong>excellent subcutaneous bioavailability<\/strong>, minimal side effects, and <strong>low systemic toxicity<\/strong>.\nDosage data from animal models do not directly translate to humans and remain for <strong>educational and scientific research purposes only<\/strong>.<\/p>\n<\/article>\n<article id=\"ruo\">\n<h3>Research Use Only (RUO)<\/h3>\n<p class=\"translation-block\">All Pepticore Aminos products, including <strong>Tesamorelin<\/strong>, are supplied strictly for <strong>laboratory and research use only<\/strong> (<em>RUO<\/em>).\nThey are not intended for diagnostic or therapeutic use in humans or animals.<\/p>\n<\/article>\n<article id=\"fonti\">\n<h3>Scientific References<\/h3>\n<ol>\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26457580\" target=\"_blank\" rel=\"noopener\">PubMed \u2014 26457580<\/a><\/li>\n<li><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa072375\" target=\"_blank\" rel=\"noopener\">New England Journal of Medicine \u2014 NEJMoa072375<\/a><\/li>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22495074\/\" target=\"_blank\" rel=\"noopener\">PubMed \u2014 22495074<\/a><\/li>\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23689947\" target=\"_blank\" rel=\"noopener\">PubMed \u2014 23689947<\/a><\/li>\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28477736\" target=\"_blank\" rel=\"noopener\">PubMed \u2014 28477736<\/a><\/li>\n<\/ol>\n<\/article>\n<\/section>","protected":false},"excerpt":{"rendered":"<p class=\"translation-block\"><strong>Tesamorelin<\/strong> is a synthetic analogue of the <strong>growth hormone\u2013releasing hormone (GHRH)<\/strong>, consisting of 44 amino acids with an added <strong>trans-3-hexanoic group<\/strong> that enhances its <strong>stability<\/strong> and <strong>half-life<\/strong>. It is researched for <strong>HIV-associated lipodystrophy<\/strong>, where it can <strong>reduce visceral fat by up to 20%<\/strong>, and for its potential roles in <strong>peripheral nerve regeneration<\/strong>, <strong>cardiometabolic health<\/strong>, and <strong>mild cognitive impairment (MCI)<\/strong>.<\/p>","protected":false},"featured_media":11396,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[50],"product_cat":[49,60,55,64,70,61],"product_tag":[],"class_list":["post-10301","product","type-product","status-publish","has-post-thumbnail","product_brand-pepticore-aminos","product_cat-metabolismo-controllo-peso","product_cat-crescita-muscolare-performance","product_cat-guarigione-recupero","product_cat-longevita-anti-aging","product_cat-peptidi-liofilizzati-fiale","product_cat-sonno-recupero","desktop-align-center","tablet-align-center","mobile-align-center","first","instock","shipping-taxable","purchasable","product-type-simple"],"acf":[],"_links":{"self":[{"href":"https:\/\/pepticoreaminos.us\/en\/wp-json\/wp\/v2\/product\/10301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pepticoreaminos.us\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/pepticoreaminos.us\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/pepticoreaminos.us\/en\/wp-json\/wp\/v2\/comments?post=10301"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pepticoreaminos.us\/en\/wp-json\/wp\/v2\/media\/11396"}],"wp:attachment":[{"href":"https:\/\/pepticoreaminos.us\/en\/wp-json\/wp\/v2\/media?parent=10301"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/pepticoreaminos.us\/en\/wp-json\/wp\/v2\/product_brand?post=10301"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/pepticoreaminos.us\/en\/wp-json\/wp\/v2\/product_cat?post=10301"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/pepticoreaminos.us\/en\/wp-json\/wp\/v2\/product_tag?post=10301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}